Browse RMM Directory A-Z

${pdf_link}$

Information for Patients - Guide to Vabysmo® (faricimab) for the Treatment of Diabetic Macular Oedema (DMO)

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

${pdf_link}$

Information for Patients - Guide to Vabysmo® (faricimab) for the Treatment of Macular oedema secondary to Central Retinal Vein Occlusion (CRVO) or Branch Retinal Vein Occlusion (BRVO)

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

${pdf_link}$

Information for Patients - Guide to Vabysmo® (faricimab) for the Treatment of Wet (Neovascular) Age-Related Macular Degeneration (AMD)

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

${pdf_link}$

Valdoxan (agomelatine) Liver Function Monitoring Scheme

This material (also included in the Prescriber guide) is provided to guide Healthcare professionals in monitoring the liver function of patients before and during treatment with Valdoxan. This material is a scheme detailing how the liver function of patients taking Valdoxan should be monitored.

${pdf_link}$

Valdoxan (agomelatine) Patient Alert Card

A Patient Card must be provided to each patient who is prescribed Valdoxan and the Prescriber should explain the importance of the liver function monitoring to the patient.

${pdf_link}$

Valdoxan (agomelatine) Prescriber Guide

This material has been developed to increase awareness about the recommendations for use for Valdoxan, in order to minimise the risk of serious liver adverse reactions. The Prescriber Guide includes guidance for Healthcare professionals in monitoring the liver function of patients before and during treatment with Valdoxan. If you require hard copy of the above materials or for further information, please contact Servier Medical Information (telephone: 01753 666409, email: [email protected])

${pdf_link}$

VANFLYTA - HCP guide: Important information for healthcare professionals about serious risks associated with Vanflyta

Important information for healthcare professionals about serious risks associated with Vanflyta

${pdf_link}$

Vanflyta (Quizartinib)- Initial- Patient Alert Card

A reminder to distribute a patient Card to any patient receiving Vanflyta treatment for the first time or if asked for a new copy

${pdf_link}$

Vaxchora effervescent powder and powder for oral suspension - RMM HCP guide

Risk Management materials guide for HCPs

${pdf_link}$

Vaxchora effervescent powder and powder for oral suspension - RMM Patient Guide

Risk management materials for patients taking Vaxchora

${pdf_link}$

RMM - Patient Guidance

Risk management materials for patients taking Vaxchora

${pdf_link}$

RMM Guide for HCPs

Risk Management materials guide for HCPs

${pdf_link}$

Velsipity (etrasimod) Checklist for Prescribers

The prescriber checklist is intended to remind the prescriber of important potential risks associated with etrasimod use and recommended tests before and during treatment.

${pdf_link}$

Velsipity (etrasimod) Patient card for women of childbearing potential

Patient card designed to enhance the awareness and knowledge of patients of childbearing potential about embryofoetal toxicity in pregnant females exposed to etrasimod and ensure the appropriate use of Velsipity.

${pdf_link}$

Velsipity (etrasimod) Patient/Caregiver Guide

The patient/caregiver guide is intended to enhance the awareness and knowledge of patients about etrasimod, including important safety information, and to ensure appropriate use of Velsipity.

${pdf_link}$

Venclyxto Patient Alert Card

Venclyxto Patient Card with safety information about Venclyxto for patients with Chronic Lymphocytic Leukaemia (CLL). This card contains information for the patient with regards to Tumour Lysis Syndrome and Venclyxto.

${pdf_link}$

Vfend Patient Alert Card

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

${pdf_link}$

Essential Information for the supply of Viagra Connect

This document contains essential information you will need to know and consider when assessing men as suitable candidates for use of VIAGRA connect. Such as understanding erectile dysfunction, who can use Viagra Connect, providing advice and patient supply/case study examples.

${pdf_link}$

Viagra Connect Pharmacy Checklist

A 2 page optional guide to help pharmacists when assessing men’s suitability for using Viagra Connect

${pdf_link}$

Volibris Patient Alert Card

This Patient Alert Card is used to facilitate regular tracking and monitoring of hepatotoxicity and teratogenicity.

${pdf_link}$

Voriconazole Patient Alert Card

This card contains important

safety information for patients given Voriconazole

${pdf_link}$

Voriconazole Healthcare Professional Checklist

Healthcare Professional Checklist to be completed at each visit.

${pdf_link}$

Voriconazole Patient Alert Card

Patient Alert card.

${pdf_link}$

Voriconazole Q&A Brochure

Healthcare Professional Q&A Brochure

${pdf_link}$

Voriconazole Milpharm HCP Q&A brochure

Question and Answer brochure intended for prescribers and other healthcare professionals involved in treatment with Voriconazole. The brochure covers important identified risks of Voriconazole and how they should be mitigated and managed

${pdf_link}$

Voriconazole Milpharm Healthcare Professional Checklist

Checklist to be completed at each visit with patients being treated with Voriconazole. Each of the three sections include important risk information followed by a series of check boxes to help in the management of patients for whom Voriconazole is being prescribed.

${pdf_link}$

Voriconazole Milpharm Patient Alert Card

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

${pdf_link}$

Voriconazole HCP Checklist

Checklist to be completed at each visit with patients being treated with Voriconazole. Each of the three sections include important risk information followed by a series of check boxes to help in the management of patients for whom voriconazole is being prescribed.

${pdf_link}$

Risk Minimisation Materials

Vabysmo

Roche Products Limited

Valdoxan

Servier Laboratories Limited

Vanflyta

Daiichi Sankyo UK Limited

Vaxchora

Bavarian Nordic UK Ltd

Patientric Limited

Velsipity

Pfizer Limited

Venclyxto

AbbVie Ltd

VFEND

Pfizer Limited

Viagra

Upjohn UK Limited

Volibris

GlaxoSmithKline UK

Voriconazole

Aristo Pharma Limited

Aspire Pharma Ltd

Aurobindo Pharma - Milpharm Ltd.

Bowmed Ibisqus Limited

Dr. Reddy's Laboratories (UK) Ltd

Pfizer Limited

VPRIV

Takeda UK Ltd

Vyndaqel

Pfizer Limited

You are trying to reach document intended for healthcare professionals only.